ArticleBMC microbiology2026
Flagellar glycosylation with pseudaminic acids is widespread in the genus Clostridium.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe ability of bacteria to chemically modify their cell surfaces through O-linked glycosylation is well characterised in Gram-negative bacteria and includes the modification of flagellin proteins with nonulosonic acids (NulOs). These modifications are widespread and have established roles in flagellar assembly, motility and virulence in various pathogens. However, there are limited documented examples of similar modifications in Gram-positive bacteria, and the significance of these is less well understood. In this study, we expand upon our previous findings that the flagellar biosynthetic locus of several pathogenic Clostridium butyricum strains contains a cluster of genes predicted to be involved in the biosynthesis of NulOs, and examine similar clusters across the whole genus Clostridium to assess the wider occurrence of NulO-mediated flagellin modification.
resultsUsing orthologues of the components of the biosynthetic pathways for the NulOs pseudaminic acid (Pse) and legionaminic acid (Leg) in the pathogenic species Campylobacter jejuni, we predict that the flagellar biosynthetic loci of several pathogenic C. butyricum strains also encode genes for these modifications. To verify this, we demonstrate that the predicted PseB orthologue encoded in the flagellar biosynthesis locus of the pathogenic strain C. butyricum 5521 is able to catalyse the first step of Pse biosynthesis. Furthermore, we show that across the genus Clostridium, genes involved in flagellar glycosylation are located in a hypervariable region (HVR) of the flagellar biosynthetic locus, which is flanked by the flagellar structural genes flgB and fliD. The content of this region differs considerably across strains and species, but remarkably over half of the Clostridium genomes encode NulO biosynthesis genes in these regions. Finally, we present evidence that suggests that this flagellar HVR has evolved independently from the rest of the genome.
conclusionsWe show that genes required for NulO-mediated flagellar glycosylation are widespread across the genus Clostridium. Our findings have potential applications in the characterisation of pathogenic strains within these species and in the engineering of strains used in industrial biotechnology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.